PEAK6 Investments’s Tandem Diabetes Care TNDM Stock Holding History

PEAK6 Investments’s Portfolio TNDM Stock Details TNDM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-5,000	Closed	-$225K	–	4972
2022 Q4	$225K	Sell	5,000 -69,400	-93%	-$3.14M	﹤0.01%	3203
2022 Q3	$3.56M	Buy	+74,400	New	+$4.08M	0.01%	1075
2022 Q1	–	Sell	-12,500	Closed	-$1.88M	–	5942
2021 Q4	$1.88M	Hold	12,500	–	–	﹤0.01%	1968
2021 Q3	$1.49M	Buy	+12,500	New	+$1.38M	﹤0.01%	2237
2021 Q1	–	Sell	-13,200	Closed	-$1.26M	–	5539
2020 Q4	$1.26M	Hold	13,200	–	–	﹤0.01%	2257
2020 Q3	$1.5M	Buy	13,200 +5,200	+65%	+$546K	﹤0.01%	1921
2020 Q2	$791K	Hold	8,000	–	–	﹤0.01%	2292
2020 Q1	$515K	Hold	8,000	–	–	﹤0.01%	2053
2019 Q4	$477K	Buy	+8,000	New	+$493K	﹤0.01%	2004

Other funds holding TNDM

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

PEAK6 Investments's TNDM Position: Q1 2023 in Review

PEAK6 Investments sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 4,941 shares — an estimated $222K sold.

PEAK6 Investments first reported a position in TNDM in Q4 2019 and held it in 6 quarters. The position peaked at $946K in Q3 2022. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

PEAK6 Investments reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
PEAK6 Investments sold 4,941 Tandem Diabetes Care shares in Q1 2023, an estimated $222K.
PEAK6 Investments first reported a position in Tandem Diabetes Care in Q4 2019 and held it in 6 quarters.
PEAK6 Investments's Tandem Diabetes Care position peaked at $946K in Q3 2022.
273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on PEAK6 Investments's 13F filing for Q1 2023, filed 12 May 2023.